- Home
- WRAP vs ZURA Comparison
WRAP vs ZURA Comparison
Compare WRAP & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRAP
- ZURA
- Stock Information
- Founded
- WRAP 2016
- ZURA 2022
- Country
- WRAP United States
- ZURA United States
- Employees
- WRAP N/A
- ZURA N/A
- Industry
- WRAP Ordnance And Accessories
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WRAP Industrials
- ZURA Health Care
- Exchange
- WRAP Nasdaq
- ZURA Nasdaq
- Market Cap
- WRAP 73.3M
- ZURA 69.9M
- IPO Year
- WRAP N/A
- ZURA N/A
- Fundamental
- Price
- WRAP $2.05
- ZURA $2.00
- Analyst Decision
- WRAP
- ZURA Buy
- Analyst Count
- WRAP 0
- ZURA 10
- Target Price
- WRAP N/A
- ZURA $12.67
- AVG Volume (30 Days)
- WRAP 338.8K
- ZURA 331.1K
- Earning Date
- WRAP 08-14-2025
- ZURA 11-06-2025
- Dividend Yield
- WRAP N/A
- ZURA N/A
- EPS Growth
- WRAP N/A
- ZURA N/A
- EPS
- WRAP N/A
- ZURA N/A
- Revenue
- WRAP $3,236,000.00
- ZURA N/A
- Revenue This Year
- WRAP N/A
- ZURA N/A
- Revenue Next Year
- WRAP N/A
- ZURA N/A
- P/E Ratio
- WRAP N/A
- ZURA N/A
- Revenue Growth
- WRAP N/A
- ZURA N/A
- 52 Week Low
- WRAP $1.20
- ZURA $0.97
- 52 Week High
- WRAP $2.58
- ZURA $5.07
- Technical
- Relative Strength Index (RSI)
- WRAP 72.82
- ZURA 55.46
- Support Level
- WRAP $1.62
- ZURA $1.97
- Resistance Level
- WRAP $1.85
- ZURA $2.19
- Average True Range (ATR)
- WRAP 0.14
- ZURA 0.14
- MACD
- WRAP 0.06
- ZURA -0.02
- Stochastic Oscillator
- WRAP 92.94
- ZURA 14.37
About WRAP Wrap Technologies Inc.
Wrap Technologies Inc is a public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel worldwide. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.